Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance

International Journal of Dermatology

Volumn 50, Issue 8, 2011, Pages 999-1001

  Prignano, Francesca ^a   Ricceri, Federica ^a   Pescitelli, Leonardo ^a   Bonciani, Diletta ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYCLOSPORIN; CYCLOSPORIN A; ETANERCEPT; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M KAPPA; LAMIVUDINE; PSORALEN; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROPHORESIS; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOFIXATION; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; PUVA; SCORING SYSTEM; SEROLOGY; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION;

EID: 79960650457     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04676.x     Document Type: Article

References (6)

1. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1: overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826-850.
2. Peterson JR, Hsu FC, Simkin PA, et al. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 2003; 62: 1078-1082.
3. Calabrese LH, Zein N, Vassilopoulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis B, hepatitis C and HIV infection. Ann Rheum Dis 2004; 63(Suppl. II): 18-24.
4. Marinos G, Naoumov NV, Rossol S, et al. Tumour necrosis factors receptors in patients with chronic hepatitis B virus infection. Gastroenterology 1995; 108: 1453-1463.
5. Carroll MB, Bond MI. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection. Semin Arthritis Rheum 2008; 38: 208-217.
6. Blade J, Rosinol L, Cibeira MT, et al. Pathogenesis and progression of monoclonal gammopathy of undetermined significance. Leukemia 2008; 22: 1651-1657.